drugset / Trial / NCT00365599
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Phase 2
Completed
43 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to explore the efficacy of vorinostat and tamoxifen combined.
Timeline
- Start
- 2006-02
- Primary completion
- 2011-04
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 20 mg | — |
| Subject | Vorinostat | Small molecule | 400 mg | Oral |